Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep;5(3):424-34.
doi: 10.1086/682431.

Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?

Affiliations
Review

Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?

Marios Panagiotou et al. Pulm Circ. 2015 Sep.

Abstract

Respiratory and limb muscle dysfunction is emerging as an important pathophysiological abnormality in pulmonary arterial hypertension (PAH). Muscle abnormalities appear to occur frequently and promote dyspnea, fatigue, and exercise limitation in patients with PAH. Preliminary data suggest that targeted muscle training may be of benefit, although further evidence is required to consolidate these findings into specific recommendations for exercise training in patients with PAH. This article reviews the current evidence on prevalence, risk factors, and implications of respiratory and limb muscle dysfunction in patients with PAH. It also reviews the impact of exercise rehabilitation on morphologic, metabolic, and functional muscle profile and outcomes in PAH. Future research priorities are highlighted.

Keywords: pulmonary arterial hypertension; rehabilitation; respiratory muscles; skeletal muscle.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Conceptual model of the factors and mechanisms that lead to muscle dysfunction in pulmonary arterial hypertension and their implications. SNA: sympathetic nerve activity.
Figure 2
Figure 2
The muscle hypothesis. Muscle work and accumulation of products of muscle metabolism during exercise lead to augmented chemoreceptor gain and ergoreceptor drive in the impaired skeletal musculature. This leads to enhanced transmission to the CNS through sensitive, afferent unmyelinated nerve fibers. The CNS responds with increased sympathetic efferent discharge to the peripheral muscles (MSNA), which causes vasoconstriction and limitation of blood flow and oxygen transportation to the exercising skeletal muscles, thus promoting fatigue and premature cessation of exercise. Finally, enhanced sympathetic drive promotes hyperventilation and breathlessness. MSNA: muscle sympathetic nerve activity; CNS: central nervous system.
Figure 3
Figure 3
Potential impact of exercise training in patients with pulmonary arterial hypertension.

References

    1. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiéry JL, Barberà JA, Beghetti M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30(20):2493–2537. - PubMed
    1. Naeije R. Breathing more with weaker respiratory muscles in pulmonary arterial hypertension. Eur Respir J 2005;25(1):6–8. - PubMed
    1. Garcia-Aymerich J, Serra I, Gómez FP, Farrero E, Balcells E, Rodriguez DA, de Batlle J, et al. Physical activity and clinical and functional status in COPD. Chest 2009;136(1):62–70. - PubMed
    1. Agustí A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don’t know (but should). Proc Am Thorac Soc 2007;4(7):522–525. - PubMed
    1. Yndestad A, Damås JK, Øie E, Ueland T, Gullestad L, Aukrust P. Systemic inflammation in heart failure—the whys and wherefores. Heart Fail Rev 2006;11(1):83–92. - PubMed

LinkOut - more resources